tirzepatide fda approval 2022 The long awaited twincretin was just approved on Friday for type 2 diabetes! π Marketed under the brand name Mounjaro, is the first dual GIP and GLP-1 receptor agonist. GIP FDA Approves Tirzepatide (Zepbound) as
Description
How do Liraglutide and Tirzepatide differ in their mechanisms of action

Tirzepatide is unlikely to cause heart palpitations for most people, but mild increases in heart rate can occur, especially in those with underlying risk factors

Congratulations to the team
Specific protocols for managing fatigue at each dose level Different doses create different challenges

Semaglutide is the most common comparison
